Literature DB >> 11306125

Active-site mutagenesis of tetanus neurotoxin implicates TYR-375 and GLU-271 in metalloproteolytic activity.

O Rossetto1, P Caccin, M Rigoni, F Tonello, N Bortoletto, R C Stevens, C Montecucco.   

Abstract

Tetanus neurotoxin (TeNT) blocks neurotransmitter release by cleaving VAMP/synaptobrevin, a membrane associated protein involved in synaptic vesicle fusion. Such activity is exerted by the N-terminal 50kDa domain of TeNT which is a zinc-dependent endopeptidase (TeNT-L-chain). Based on the three-dimensional structure of botulinum neurotoxin serotype A (BoNT/A) and serotype B (BoNT/B), two proteins closely related to TeNT, and on X-ray scattering studies of TeNT, we have designed mutations at two active site residues to probe their involvement in activity. The active site of metalloproteases is composed of a primary sphere of residues co-ordinating the zinc atom, and a secondary sphere of residues that determines proteolytic specificity and activity. Glu-261 and Glu-267 directly co-ordinates the zinc atom in BoNT/A and BoNT/B respectively and the corresponding residue of TeNT was replaced by Asp or by the non conservative residue Ala. Tyr-365 is 4.3A away from zinc in BoNT/A, and the corresponding residue of TeNT was replaced by Phe or by Ala. The purified mutants had CD, fluorescence and UV spectra closely similar to those of the wild-type molecule. The proteolytic activity of TeNT-Asp-271 (E271D) is similar to that of the native molecule, whereas that of TeNT-Phe-375 (Y375F) is lower than the control. Interestingly, the two Ala mutants are completely devoid of enzymatic activity. These results demonstrate that both Glu-271 and Tyr-375 are essential for the proteolytic activity of TeNT.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11306125     DOI: 10.1016/s0041-0101(00)00252-x

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  8 in total

Review 1.  The blockade of the neurotransmitter release apparatus by botulinum neurotoxins.

Authors:  Sergio Pantano; Cesare Montecucco
Journal:  Cell Mol Life Sci       Date:  2013-06-11       Impact factor: 9.261

2.  The structure of the tetanus toxin reveals pH-mediated domain dynamics.

Authors:  Geoffrey Masuyer; Julian Conrad; Pål Stenmark
Journal:  EMBO Rep       Date:  2017-06-23       Impact factor: 8.807

3.  SNAP-23 functions in docking/fusion of granules at low Ca2+.

Authors:  Evelina Chieregatti; Michael C Chicka; Edwin R Chapman; Giulia Baldini
Journal:  Mol Biol Cell       Date:  2004-01-23       Impact factor: 4.138

Review 4.  Anthrax lethal toxin and the induction of CD4 T cell immunity.

Authors:  Stephanie Ascough; Rebecca J Ingram; Daniel M Altmann
Journal:  Toxins (Basel)       Date:  2012-10-19       Impact factor: 4.546

Review 5.  Clostridial neurotoxins: mechanism of SNARE cleavage and outlook on potential substrate specificity reengineering.

Authors:  Thomas Binz; Stefan Sikorra; Stefan Mahrhold
Journal:  Toxins (Basel)       Date:  2010-04-13       Impact factor: 4.546

6.  Electrophysiological Characterization of the Antarease Metalloprotease from Tityus serrulatus Venom.

Authors:  Irene Zornetta; Michele Scorzeto; Pablo Victor Mendes Dos Reis; Maria E De Lima; Cesare Montecucco; Aram Megighian; Ornella Rossetto
Journal:  Toxins (Basel)       Date:  2017-02-27       Impact factor: 4.546

7.  Bioinformatic discovery of a toxin family in Chryseobacterium piperi with sequence similarity to botulinum neurotoxins.

Authors:  Michael James Mansfield; Travis Gwynn Wentz; Sicai Zhang; Elliot Jeon Lee; Min Dong; Shashi Kant Sharma; Andrew Charles Doxey
Journal:  Sci Rep       Date:  2019-02-07       Impact factor: 4.379

8.  Construction and validation of safe Clostridium botulinum Group II surrogate strain producing inactive botulinum neurotoxin type E toxoid.

Authors:  Maria B Nowakowska; Katja Selby; Adina Przykopanski; Maren Krüger; Nadja Krez; Brigitte G Dorner; Martin B Dorner; Rongsheng Jin; Nigel P Minton; Andreas Rummel; Miia Lindström
Journal:  Sci Rep       Date:  2022-02-02       Impact factor: 4.996

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.